Stock INVO INVO BIOSCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus INVO Bioscience, Inc.

Equities

INVO

US44984F4019

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.98 USD -0.01% Intraday chart for INVO Bioscience, Inc. -28.47% -27.41%
Apr. 18 Top Premarket Decliners MT
Apr. 17 Sector Update: Health Care Stocks Retreating Late Afternoon MT

Evolution of the average Target Price on INVO Bioscience, Inc.

Price target over the last 5 years

History of analyst recommendation changes

302.YnNw-LGqXLvjFbmuFNko1obQbGdU8ehH_a7MR5hJQdE.DB1EqN7TOfWTe-GDYetn4uyBBTQ_yYIGtPeqNOggMKgPJjq-iMYR1bpf1g~015f790170ed6870e9d6f43180a2055d

Analyst Recommendations on INVO Bioscience, Inc.

Roth Capital Downgrades INVO Bioscience to Neutral From Buy, Adjusts Price Target to $2 From $4 MT
Maxim Starts INVO Bioscience at Buy with $7 Price Target MT
INVO BIOSCIENCE : Roth Capital Starts INVO Bioscience at Buy With $5.75 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.98
Average target price
-

Consensus detail

Consensus revision (last 18 months)

Analysts covering INVO Bioscience, Inc.

Roth Capital Partners
Maxim

Ratings for INVO Bioscience, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. INVO Stock
  4. Consensus INVO Bioscience, Inc.